Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China

Molecular Diagnosis and Therapy

Volumn 15, Issue 1, 2011, Pages 41-52

  Xu, Sihong ^a   Zhong, Ping ^b   Li, Jingyun ^c   Song, Aijing ^a   Li, Hanping ^c   Nie, Jianhui ^a   Li, Xiuhua ^a   Wang, Youchun ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^b Shanghai Center for Disease Prevention and Control   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL RESISTANCE; ARTICLE; ASSAY; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; STRUCTURAL GENE; VIROSEQ;

ANTI-RETROVIRAL AGENTS; CHINA; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS, RNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79953778464     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.2165/11588860-000000000-00000     Document Type: Article

References (36)

1. Hammer SM, Eron Jr JJ, Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA Panel. JAMA 2008; 300: 555-70
2. Stanford University HIV Drug Resistance Database [SU-HIVdb]. Antiretroviral drug prescribing information [online]. Available from URL: http:// hivdb.stanford.edu/pages/links.html#Drug%20Info [Accessed 2011 Feb 15]
3. Metzner KJ, Giulieri SG, Knoepfel SA, et al. Minority quasispecies of drugresistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. Clin Infect Dis 2009; 48: 239-47
4. Babafemi T. Understanding transmittedHIV resistance through the experience in the USA. Int J Infect Dis 2009; 13: 552-9
5. Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989; 243: 1731-4 (Pubitemid 19106971)
6. Yerly S, Kaiser L, Race E, et al. Transmission of antiretroviral-drug- resistant HIV-1 variants. Lancet 1999; 354: 729-33 (Pubitemid 29407396)
7. Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med 2009; 17: 138-45
8. Durant J, Clevenbergh P, Halfon P, et al. Drugresistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. Lancet 1999; 353: 2195-9 (Pubitemid 29295252)
9. Novak RM, Chen L, MacArthur RD, et al. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis 2005; 40: 468-74 (Pubitemid 40216518)
10. Han XX, Zhang M, Cui WG, et al. Efficacy of anti-HIV treatment and drugresistance mutations in some parts of China [in Chinese]. Zhonghua Yi Xue Za Zhi 2005; 85: 760-4 (Pubitemid 40468047)
11. Li JY, Li HP, Li L, et al. Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 2005; 15: 843-9 (Pubitemid 41826249)
12. Yang K, Li JY, Bao ZY, et al. Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naive AIDS patients in Henan province [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26: 351-5
13. Zhong P, Pan Q, Ning Z, et al. Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 2007; 23: 847-56 (Pubitemid 47267490)
14. Luo M, Liu H, Zhuang K, et al. Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the Peoples Republic of China. J Acquir Immune Defic Syndr 2009; 50: 1-8
15. Liao L, Xing H, Shang H, et al. The prevalence of drug resistance in treatment naïve HIV-infected individuals in China. J Acquir Immune Defic Syndr 2010; 53: S10-4
16. Yang R, Kusagawa S, Zhang C, et al. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07-BC and CRF08-BC, in China. J Virol 2003; 77: 685-95 (Pubitemid 36005005)
17. Zhang L, Chen Z, Cao Y, et al. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in China. J Virol 2004; 78: 13591-9 (Pubitemid 39612759)
18. Zhang Y, Lu L, Ba L, et al. Dominance of HIV-1 subtype CRF01-AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med 2006; 3: e443
19. Lu L, Jia M, Ma Y, et al. The changing face of HIV in China. Nature 2008; 455: 609-11
20. Shafer RW. Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev 2002; 15: 247-77 (Pubitemid 34303765)
21. Demeter L, Haubrich R. International perspectives on antiretroviral resistance: phenotypic and genotypic resistance assays. Methodology, reliability, and interpretations. J Acquir Immune Defic Syndr 2001; 26 Suppl. 1: S3-9
22. Shafer RW, Warford A, Winters MA, et al. Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals. J Virol Methods 2000; 86: 143-53 (Pubitemid 30227491)
23. Xu S, Li J, Bao Z, et al. Development and evaluation of a national reference panel of HIV-1 protease and reverse transcriptase drug-resistance mutations for HIV-1 genotypic resistance assays in China. Mol Diagn Ther 2010; 14: 31-41
24. Baxter JD, Mayers DL, Wentworth DN, et al. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. AIDS 2000; 14: F83-93 (Pubitemid 30420686)
25. Abbott Laboratories. ViroSeq V2.7: instructions for use. Abbott Park (IL): Abbott Laboratories, 2007: 50-1
26. Eshleman SH, Crutcher G, Petrauskene O, et al. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI Prism 3100 genetic analyzer. J Clin Microbiol 2005; 43: 813-7 (Pubitemid 40256039)
27. Cunningham S, Ank B, Lewis D, et al. Performance of the Applied Biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples. J Clin Microbiol 2001; 39: 1254-7 (Pubitemid 32275416)
28. Mracna M, Becker-Pergola G, Dileanis J, et al. Performance of Applied Biosystems ViroSeq HIV-1 genotyping system for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda. J Clin Microbiol 2001; 39: 4323-7 (Pubitemid 33117117)
29. Eshleman SH, Hackett JJ, Swanson P, et al. Performance of the Celera Diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J Clin Microbiol 2004; 42: 2711-7 (Pubitemid 38747526)
30. Church JD, JonesD, Flys T, et al. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. J Mol Diagn 2006; 8: 430-2 (Pubitemid 44377924)
31. Yang Z, Morrison R, Oates C, et al. HIV-1 genotypic resistance testing on low viral load specimens using the Abbott ViroSeq HIV-1 genotyping system. Lab Med, 2008; 39: 671-3
32. Maes B, Schrooten Y, Snoeck J, et al. Performance of ViroSeq HIV-1 genotyping system in routine practice at a Belgian clinical laboratory. J Virol Methods 2004; 119: 45-9 (Pubitemid 38510526)
33. Chen JH, Wong KH, Chan K, et al. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping. J Clin Virol 2007; 39: 125-31 (Pubitemid 46777426)
34. Fraf M, Shao Y, Zhao Q, et al. Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses 1998; 14: 285-8 (Pubitemid 28084024)
35. Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000; 74: 11286-95 (Pubitemid 32223998)
36. Huang DD, Eshleman SH, Brambilla DJ, et al. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. JClin Microbiol 2003; 41: 3265-72 (Pubitemid 36842332)